Bausch Health Companies | VRX - Gewinn Vor Steuern

Aktienkurs
6.81
Täglich Wechseln
-0.21 -2.99%
Monatlich
-18.64%
Jährlich
-31.90%
Q1 Prognose
6.73




Gewinn Vor Steuern Veränderung Datum
Amgen USD 3.92B 2.35B 2025-09
ANI Pharmaceuticals USD 49.52M 39M 2025-09
Aurora Cannabis CAD -1.58M 48.55M 2025-12
Bausch Health Companies USD 218M 78M 2025-09
Biogen USD 557.3M 186.7M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Canopy Growth CAD -62.26M 60.84M 2025-12
Corcept Therapeutics USD 15.24M 16.45M 2025-09
Danaher USD 1.08B 421M 2025-09
Drreddys Laboratories INR 15.43B 1.96B 2025-12
Eli Lilly USD 7.23B 456M 2025-09
Gilead Sciences USD 3.64B 1.21B 2025-09
Nektar Therapeutics USD -37.05M 15.27M 2024-09
Novo Nordisk DKK 33.8B 3.23B 2025-06
Pacira USD 9.52M 11.45M 2025-09
Perrigo USD 22.4M 19.2M 2025-09
Phibro Animal Health USD 38.62M 1.26M 2025-12
Prestige Brands USD 69.13M 7.35M 2025-09
Supernus Pharmaceuticals USD -1.91M 56.04M 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09
Zoetis USD 887M 15M 2025-09